Inclusion criteria |
1. Aged 18 years or above |
2. Diagnosed with chronic heart failure |
3. Clinically stable, defined as symptoms/signs that have remained generally unchanged for ≥ 1 month |
4. New York Heart Association functional classification of II or III |
5. Informed consent provided |
Exclusion criteria |
1. Patients who have contraindications to exercise testing: early phase after acute coronary syndrome (up to 6 weeks); life-threatening cardiac arrhythmias; acute heart failure (during the initial period of hemodynamic instability); uncontrolled hypertension (systolic blood pressure > 200 mmHg and/or diastolic blood pressure > 110 mmHg); advanced atrioventricular block; acute myocarditis and pericarditis; moderate to severe aortic/mitral stenosis; severe aortic/mitral regurgitation; severe hypertrophic obstructive cardiomyopathy; acute systemic illness; or intracardiac thrombus. |
2. Patients who have contraindications to exercise training: progressive worsening of exercise tolerance or dyspnea at rest over the previous week; significant ischemia during low-intensity exercise (< 2 metabolic equivalents, < 50 W); uncontrolled diabetes; recent embolism; thrombophlebitis; or new-onset atrial fibrillation/atrial flutter |
3. Patients who have serious acute or chronic disease affecting major organs, or mental disorders |
4. History of cardiac surgery, cardiac resynchronization therapy, intracardiac defibrillation, or implantation of combined device within the previous 3 months |
5. History of cardiac arrest within 1 year |
6. History of peripartum cardiomyopathy, hyperthyroid heart disease, primary pulmonary hypertension |
7. Inability to perform a bicycle stress test |
8. Severe cognitive dysfunction precluding understanding of exercise concepts |
9. Current participation in either Baduanjin or a conventional cardiac rehabilitation program |
10. Participation in a concurrent trial |